Evidence map›Paper›PMID 26013963›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Oxytocin Stimulates Extracellular Ca2+ Influx Through TRPV2 Channels in Hypothalamic Neurons to Exert Its Anxiolytic Effects.

Erwin H van den Burg, Julia Stindl, Thomas Grund, Inga D Neumann, Olaf Strauss

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Activation of VNeuropharmacology · 2021
    Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Erwin H van den BurgDepartment of Behavioural and Molecular Neurobiology, Institute of Zoology, University of Regensburg, Regensburg, Germany.
Julia StindlDepartment of Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg, Regensburg, Germany.
Thomas GrundDepartment of Behavioural and Molecular Neurobiology, Institute of Zoology, University of Regensburg, Regensburg, Germany.
Inga D NeumannDepartment of Behavioural and Molecular Neurobiology, Institute of Zoology, University of Regensburg, Regensburg, Germany.
Olaf StraussDepartment of Experimental Ophthalmology, Eye Hospital, University Medical Center Regensburg, Regensburg, Germany.
University of Regensburg · DECharité - Universitätsmedizin Berlin · DEUniversity Hospital Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is growing interest in anxiolytic and pro-social effects of the neuropeptide oxytocin (OXT), but the underlying intraneuronal mechanisms are largely unknown. Here we examined OXT-mediated anxiolysis in the hypothalamic paraventricular nucleus (PVN) of rats and effects of OXT administration on signaling events in hypothalamic primary and immortalized cells. In vivo, the application of SKF96365 prevented the anxiolytic activity of OXT in the PVN, suggesting that changes in intracellular Ca(2+) mediate the acute OXT behavioral effects. In vitro, mainly in the neurons with autonomous Ca(2+) oscillations, OXT increased intracellular Ca(2+) concentration and oscillation amplitude. Pharmacological intervention revealed OXT-dependent changes in Ca(2+) signaling that required activation of transient receptor potential vanilloid type-2 channel (TRPV2), mediated by phosphoinositide 3-kinase. TRPV2 induced the activation of the anxiolytic mitogen-activated protein kinase kinase (MEK1/2). In situ, immunohistochemistry revealed co-localization of TRPV2 and OXT in the PVN. Thus, functional and pharmacological analyses identified TRPV2 as a mediator of anxiolytic effects of OXT, conveying the OXT signal to MEK1/2 via modulation of intracellular Ca(2+).

Indexed as

AnimalsAnti-Anxiety AgentsAnxietyCalciumCalcium Channel BlockersCalcium SignalingCations, DivalentCells, CulturedDrug Evaluation, PreclinicalExtracellular SpaceImidazolesMaleMotor ActivityNeuronsOxytocinParaventricular Hypothalamic Nucleus1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazoleAnti-Anxiety AgentsCalciumCalcium Channel BlockersCations, DivalentImidazolesOxytocinPhosphatidylinositol 3-KinasesReceptors, OxytocinTrpv2 protein, ratTRPV Cation Channels

Identifiers

PMID26013963
PMCPMC4864629
OpenAlexW1573760242

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.